
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. (XFOR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · XFOR · as of Jun 9, 2026
Key Statistics
Explore X4 Pharmaceuticals, Inc. Data
xfor stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 92.3%
The XFOR analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +223.45% upside from the current price of $3.71.
Competitors & Peers
xfor competitorsStock Performance
Full HistoryAbout X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. is a biopharmaceutical firm committed to the discovery, development, and commercialization of innovative therapies for uncommon immune system disorders. Its primary drug candi…
what is x4 pharmaceuticals, inc. · xfor stock overview · x4 pharmaceuticals, inc. company profile · who is x4 pharmaceuticals, inc. ceo · xfor NASDAQ · x4 pharmaceuticals, inc. headquarters · x4 pharmaceuticals, inc. business segments
About Stock Overview & Key Data
X4 Pharmaceuticals, Inc. (XFOR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 16, 2017. As of the latest trading session, XFOR stock price is $3.71, with a market capitalization of $349.9M. The stock has returned -10.39% over the past 12 months and -7.25% year-to-date.
According to 13 Wall Street analysts, the consensus rating for X4 Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, X4 Pharmaceuticals, Inc. reported revenue of $35.1M and net income of -$79.2M. For detailed data — including X4 Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, X4 Pharmaceuticals, Inc. (XFOR) stock price is $3.71. The stock is traded on NASDAQ under the ticker symbol XFOR. The 52-week range is $1.35 – $4.83.